![Brian Gallagher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brian Gallagher
Director/Board Member at
Nimbus Apollo, Inc.
Profile
Brian M.
Gallagher's current jobs include being a Director at eFFECTOR Therapeutics Operations, Inc., Nimbus Apollo, Inc., and Slate Bio, Inc. Formerly, Dr. Gallagher served as the Chairman at eFFECTOR Therapeutics, Inc. from 2021 to 2024.
He was also a Director at CalciMedica Subsidiary, Inc. from 2013 to 2018, Aileron Therapeutics, Inc. from 2010 to 2018, Nimbus Therapeutics LLC from 2011 to 2018, Translate Bio, Inc. from 2011 to 2019, River Vision Development Corp.
from 2012 to 2017, Navitor Pharmaceuticals, Inc. from 2014 to 2018, and GSK Equity Investments Ltd. from 2010 to 2018.
Additionally, he held positions as a Director at Dicerna Pharmaceuticals, Inc., SpringLeaf Therapeutics, Inc., and Constellation Pharmaceuticals, Inc. Dr. Gallagher's education includes graduate and doctorate degrees from the University of Michigan.
Brian Gallagher active positions
| Companies | Position | Start |
|---|---|---|
Nimbus Apollo, Inc.
 Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery research services | Director/Board Member | - |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. BiotechnologyHealth Technology Operates a clinical-stage biopharmaceutical company that develops oncology drugs | Director/Board Member | - |
Slate Bio, Inc.
 Slate Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which creates therapies that restore body's natural immunological diseases | Director/Board Member | - |
Former positions of Brian Gallagher
| Companies | Position | End |
|---|---|---|
| EFFECTOR THERAPEUTICS, INC. | Chairman | 2024-06-20 |
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Director/Board Member | 2022-12-30 |
Abingworth Management, Inc.
 Abingworth Management, Inc. Investment ManagersFinance Acts as an alternative investment manager | Private Equity Investor | 2021-12-31 |
| TRANSLATE BIO, INC. | Director/Board Member | 2018-12-31 |
| REIN THERAPEUTICS INC. | Director/Board Member | 2018-03-18 |
Training of Brian Gallagher
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
54
1st degree connections
21
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 21 |
|---|---|
Eisai Co., Ltd.
 Eisai Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research, development, manufacturing and sales of prescription and over-the-counter drugs | Commercial Services |
Sirtris Pharmaceuticals, Inc.
 Sirtris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs and pharmaceuticals | Health Technology |
Alantos Pharmaceuticals Holding, Inc.
 Alantos Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
CalciMedica Subsidiary, Inc.
 CalciMedica Subsidiary, Inc. BiotechnologyHealth Technology Engages in drug development | Health Technology |
Rein Therapeutics, Inc.
 Rein Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops stapled peptide drugs | Health Technology |
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on discovering, developing and commercializing medicines for chronic liver diseases | Health Technology |
SpringLeaf Therapeutics, Inc.
 SpringLeaf Therapeutics, Inc. Drugstore ChainsRetail Trade Develops various drug delivery technologies | Retail Trade |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Operates as a clinical stage biotech company that develops molecule medicines for diseases like cancer, immune disorders and metabolic conditions | Health Technology |
Translate Bio, Inc.
 Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein | Health Technology |
River Vision Development Corp.
 River Vision Development Corp. BiotechnologyHealth Technology Develops novel protein therapies for treatment of graves orbitopathy | Health Technology |
Navitor Pharmaceuticals, Inc.
 Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted therapeutics | Health Technology |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Finance |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abingworth Management, Inc.
Abingworth Management, Inc. Investment ManagersFinance Acts as an alternative investment manager | Finance |
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs targeting regulators of epigenetic function | Health Technology |
eFFECTOR Therapeutics Operations, Inc.
eFFECTOR Therapeutics Operations, Inc. BiotechnologyHealth Technology Operates a clinical-stage biopharmaceutical company that develops oncology drugs | Health Technology |
Nimbus Apollo, Inc.
Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery research services | Health Technology |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Health Technology |
Slate Bio, Inc.
Slate Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which creates therapies that restore body's natural immunological diseases | Health Technology |
eFFECTOR Therapeutics, Inc.
 eFFECTOR Therapeutics, Inc. BiotechnologyHealth Technology Operates as a oncology company which develops therapies for cancer | Health Technology |
- Stock Market
- Insiders
- Brian Gallagher
